People's Health Press
ISSN 2096-2738 CN 11-9370/R
  • Official WeChat

  • Official Weibo

  • Official headlines

Electronic Journal of Emerging Infectious Diseases ›› 2023, Vol. 8 ›› Issue (5): 59-62.doi: 10.19871/j.cnki.xfcrbzz.2023.05.012

• Case Report • Previous Articles     Next Articles

Pharmacological intervention and monitoring of a baby with tuberculous meningitis combined with purulent meningitis

Wei Wenfang1, Yu Haiwei1, Qin Simei2, Jiang Changyue1   

  1. 1. Department of Pharmacy, the Fourth People's Hospital of Nanning, Guangxi Nanning 530023, China;
    2. Department of Pediatrics, the Fourth People's Hospital of Nanning, Guangxi Nanning 530023, China
  • Received:2022-12-20 Online:2023-10-31 Published:2023-12-05

Abstract: This article reviews on the proactive intervention and monitoring of a scientific pharmacist in the administration of an child with tuberculous meningitis blended with purulent meningitis. The patient, a 6-month and 3-day-old child, was diagnosed with tuberculous meningitis, purulent meningitis, and secondary epilepsy. The clinical pharmacist notified the clinic about the potential drug interactions between meropenem and sodium valproate, which could worsen the seizures. After consulting with the healthcare team, the child's convulsions were gradually controlled. The frequency of linezolid was adjusted from every 8 hours to every 12 hours. After adjusting the frequency of linezolid for three days, the child exhibited the ability to track light and objects with both eyes. Following this improvement, the child was discharged and scheduled for regular check-ups. The anti-tuberculosis regimen was continued for nearly 10 months with adjusted frequency of linezolid, and no further adverse drug reactions were reported.

Key words: Clinical pharmacist, Tuberculous meningitis, Purulent meningitis, Drug interactions, Adverse reactions, Infant

CLC Number: